Online citations, reference lists, and bibliographies.
← Back to Search

Heterogeneity In Breast Cancer.

K. Polyak
Published 2011 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Breast cancer is a heterogeneous disease. There is a high degree of diversity between and within tumors as well as among cancer-bearing individuals, and all of these factors together determine the risk of disease progression and therapeutic resistance. Advances in technologies such as whole-genome sequencing and functional viability screens now allow us to analyze tumors at unprecedented depths. However, translating this increasing knowledge into clinical practice remains a challenge in part due to tumor evolution driven by the diversity of cancer cell populations and their microenvironment. The articles in this Review series discuss recent advances in our understanding of breast tumor heterogeneity, therapies tailored based on this knowledge, and future ways of assessing and treating heterogeneous tumors.
This paper references
10.1172/JCI45014
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
B. Lehmann (2011)
10.1038/nature09515
Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer
S. Yachida (2010)
10.1186/bcr2635
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
A. Prat (2010)
10.1073/pnas.0711613105
BRCA1 regulates human mammary stem/progenitor cell fate
S. Liu (2008)
10.1016/j.stem.2010.12.007
Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate.
Theresa A. Proia (2011)
10.1038/nature07567
Efficient tumor formation by single human melanoma cells
Elsa Quintana (2008)
10.1016/j.bbcan.2009.11.002
Tumor heterogeneity: causes and consequences.
A. Marusyk (2010)
10.1172/JCI57099
Breast cancer stem cells, cytokine networks, and the tumor microenvironment.
H. Korkaya (2011)
10.1016/j.ccr.2010.10.012
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.
Elsa Quintana (2010)
10.1158/0008-5472.CAN-10-0538
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.
S. Liu (2011)
10.1016/j.cell.2010.11.055
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
P. Stephens (2011)
10.1172/JCI44745
The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.
Lauren L C Marotta (2011)
Efficient tumour formation by single human melanoma cells
Elsa Quintana (2008)
10.1038/35021093
Molecular portraits of human breast tumours
C. Perou (2000)
10.1172/JCI57152
Targeted therapies for breast cancer.
M. Higgins (2011)
10.1172/JCI40724
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.
S. Y. Park (2010)
10.1172/JCI33295
Breast cancer: origins and evolution.
K. Polyak (2007)
10.1038/nm.2000
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
E. Lim (2009)
10.1038/nature09650
Genetic variegation of clonal architecture and propagating cells in leukaemia
K. Anderson (2011)
10.1038/367645A0
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
T. Lapidot (1994)
10.1038/nature09807
Tumour evolution inferred by single-cell sequencing
N. Navin (2011)
10.1016/0092-8674(90)90186-I
A genetic model for colorectal tumorigenesis
E. Fearon (1990)
10.1126/scitranslmed.3000611
Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients
Hege G. Russnes (2010)
10.1038/nature09733
Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells
F. Notta (2011)
10.1073/pnas.191367098
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T. Sørlie (2001)
10.1073/pnas.0530291100
Prospective identification of tumorigenic breast cancer cells
M. Al-Hajj (2003)
10.1634/theoncologist.2011-S1-20
Breast cancer management: opportunities and barriers to an individualized approach.
E. Perez (2011)
10.1038/nature08645
COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES
P. Stephens (2009)
10.1172/JCI57100
Breast cancer - one term, many entities?
N. Bertos (2011)
10.1073/pnas.1009117107
A mathematical framework to determine the temporal sequence of somatic genetic events in cancer
Camille Stephan-Otto Attolini (2010)
10.1073/pnas.0712345105
Comparative lesion sequencing provides insights into tumor evolution
S. Jones (2008)
10.1016/J.YONC.2011.08.045
Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells
R. Arceci (2011)
10.1038/nature08489
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
S. Shah (2009)
10.1073/pnas.1102454108
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Christine L Chaffer (2011)
10.1172/JCI57088
Insight into the heterogeneity of breast cancer through next-generation sequencing.
H. Russnes (2011)



This paper is referenced by
10.1038/bjc.2013.40
Oxidative stress specifically downregulates survivin to promote breast tumour formation
S. Pervin (2013)
10.1117/12.2293047
Analysis of DCE-MRI features in tumor and the surrounding stroma for prediction of Ki-67 proliferation status in breast cancer
H. Li (2018)
10.1002/pon.4764
Quality of life among women diagnosed with breast Cancer: A randomized waitlist controlled trial of commercially available mobile app‐delivered mindfulness training
Kristen D Rosen (2018)
10.1007/978-1-4899-8065-6_2
MicroRNAs in Cancer Progression
Omozusi E. Andrews (2014)
Loss of FBP 1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-Like Breast Cancer
S. Miriyala (2017)
Protein Regulators of Phosphoinositides as Promoters of Cancer Metastasis
Caitlin A Sengelaub (2016)
10.3892/mmr.2018.8885
Silencing of casein kinase 2 inhibits PKC‑induced cell invasion by targeting MMP‑9 in MCF‑7 cells.
J. Kim (2018)
BASIS FOR TARGETING MET ACTIVATION MEDIATED RESISTANCE TO PI3K INHIBITION IN BREAST CANCER
A. González-Angulo (2013)
I. Development of novel silicon precursors for rapid and efficient radiofluorination reactions: synthesis and biological evaluation of a 18f-labelled estrogen dendrimer conjugate II. Other studies on 18f-labelled estrogens
V. Carroll (2012)
10.1007/s12079-012-0158-2
CCN5/WISP-2: A micromanager of breast cancer progression
S. Banerjee (2012)
10.1039/d0ra04970k
Design, synthesis, and biological evaluation of new 6,N2-diaryl-1,3,5-triazine-2,4-diamines as anticancer agents selectively targeting triple negative breast cancer cells
A. Junaid (2020)
10.1089/ars.2015.6457
Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
A. Jo (2017)
10.2147/CMAR.S198348
Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma
R. Farid (2019)
10.1002/jmri.26556
Role of texture analysis in breast MRI as a cancer biomarker: A review
Rhea D Chitalia (2019)
10.1080/14728222.2017.1381087
Fatty acid synthase (FASN) as a therapeutic target in breast cancer
J. Menéndez (2017)
10.1186/1471-2407-13-537
Wnt signaling in triple negative breast cancer is associated with metastasis
N. Dey (2013)
10.1016/j.biopha.2016.05.007
Plumbagin triggers DNA damage response, telomere dysfunction and genome instability of human breast cancer cells.
Safoura Sameni (2016)
10.1016/j.bbcan.2016.01.005
Do cell-autonomous and non-cell-autonomous effects drive the structure of tumor ecosystems?
Tazzio Tissot (2016)
Toll-like receptor mediated regulation of breast cancer: a case of mixed blessings
Christophe M. Filippi (2014)
10.1038/srep16941
Mesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-β
Kathleen M McAndrews (2015)
10.1002/ijc.28685
Heterogeneity of epidemiological factors by breast tumor subtypes in Korean women: A case–case study
N. Song (2014)
10.2174/0929867325666180912104707
Targeting Nodal and Cripto-1: perspectives inside dual potential theranostic cancer biomarkers.
A. Sandomenico (2018)
10.19080/jdvs.2017.01.555552
Laser Micro Dissection Systems: An Alternative Method of Defined Cell Isolation for Molecular Profiling
R. Choudhary (2017)
10.1093/bib/bbz118
Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer
Siqi Bao (2020)
10.3390/genes9100478
An Improved Method for Prediction of Cancer Prognosis by Network Learning
Minseon Kim (2018)
10.1172/JCI77767
An epigenetically distinct breast cancer cell subpopulation promotes collective invasion.
Jill M. Westcott (2015)
10.1186/1471-2407-14-237
Tumour-associated endothelial-FAK correlated with molecular sub-type and prognostic factors in invasive breast cancer
A. Alexopoulou (2013)
10.1016/j.jmir.2017.09.006
Imaging Biomarkers for Precision Medicine in Locally Advanced Breast Cancer.
W. Tran (2018)
10.1155/2020/9160905
The Emerging Role of MicroRNAs in Breast Cancer
Zhiguang Yang (2020)
10.1117/12.2513095
Heterogeneity of tumor and its surrounding stroma on DCE-MRI and diffusion weighted imaging in predicting histological grade and lymph node status of breast cancer
Qingmei Chen (2019)
Deciphering the Functions of Ets2, Pten and p53 in Stromal Fibroblasts in Multiple Breast Cancer Models
J. Wallace (2013)
10.3390/ijms21082995
Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin
Renata Machado Brandão-Costa (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar